A new partnership was announced by Novartis and Microsoft that could become a transformative venue for drug discovery and research with the use of artificial intelligence. The multi-year agreement will also involve joint research initiatives and co-working environments at the Microsoft Research Lab in the UK, the Novartis Global Service Centre in Ireland and the Novartis Campus in Switzerland.
Novartis, Microsoft partner for AI-driven research collaboration
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.